by Jasmine C, B Jamerson | Apr 22, 2025 | Arthritis, Health and Medical Research News
What did the research discover? Researchers examined biosimilar drugs as a cost-effective alternative to biologic disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Biosimilars of adalimumab, etanercept, infliximab, and rituximab have been...
by Jasmine C, B Jamerson | Apr 22, 2025 | 2023 Approvals, Drug approvals, New Drugs Approved
What is Brixadi prescribed for? Brixadi is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with...
by Jasmine C, B Jamerson | Apr 22, 2025 | Eye, Health and Medical Research News
What Did the Research Discover? Researchers studied how vision works and what happens when certain parts of the eye stop functioning properly. They focused on the retina, the thin layer of tissue at the back of the eye that helps us see by turning light into signals...
by Jasmine C | Apr 21, 2025 | Diabetes, Health and Medical Research News, Trending News
What is this alert about? In April 2025, the drug company Novo Nordisk told the U.S. Food and Drug Administration (FDA) that fake versions of Ozempic (semaglutide) were found in the U.S. drug supply. Ozempic is a prescription medicine used to help adults with type 2...
by Jasmine C, B Jamerson | Apr 21, 2025 | Health and Medical Research News, Skin Conditions, Trending News
What Did the Research Discover? Post-inflammatory hyperpigmentation (PIH) is a condition where dark spots appear on the skin after an injury, inflammation, or irritation. It is especially challenging to treat in people with darker skin tones (Fitzpatrick skin types...
